Bookmarks
African Network for Drugs and Diagnostics Innovation (ANDI)Vision: " Creating a sustainable platform for R&D innovation in Africa to address Africa’s own health needs" The African Network for Drugs and Diagnostics Innovation (ANDI) was launched in Abuja in 2008. Its goal is to promote and sustain African-led product R&D innovation through the discovery, development and delivery of affordable new tools, including those based on traditional medicines. ANDI will also support capacity and infrastructural development. A task force was established to develop the strategic and business plan for ANDI through a broad consultative process. This plan is seen as an important contribution towards the implementation of the Global Strategy on Public Health, Innovation and Intellectual Property (GSPOA). ANDI is a coordinated and results-driven effort that builds on existing activities in Africa. With strong elements of public-private partnerships, it generates and manages intellectual property and explores innovative mechanisms to encourage and reward local innovation. The new group will identify, manage and grant funding to support network activities, while proactively establishing sustainable funding mechanisms for its operations
Saved once
(save)
Bookmarked by The Editorial Team on 17 Sep 2010
|
Blog posts
Survey: What do you want from a diagnostic kit?
This blog is closed to new posts due to inactivity. The post remains here as part of the network’s archive ...
Clinical trials of diagnostics
This blog is closed to new posts due to inactivity. The post remains here as part of the network’s archive ...
Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
by Voermans et al.Comparison of Zika virus quantitative reverse transcription PCR results in single timepoint whole blood–plasma pairs from 227 patients with suspected Zika virus infection resulted in confirmation of 8 additional patients with Zika virus infection.
The difficulties in obtaining reliable Zika virus diagnostics
by Fischer et al.Correspondence re: Familiar barriers still unresolved - a perspective on the Zika virus outbreak research response
Recurrent recent arbovirus infections suggested by serologic data and unspecific symptoms highlight the need for exhaustive virologic testing.
Familiar barriers still unresolved - a perspective on the Zika virus outbreak research response
by Koopmans et al.The authors of this study have identified three major bottlenecks in the implementation of a swift response to the increasing frequency of widespread infectious disease outbreaks: the absence of a timeline for the funding process, delays in regulatory and ethical approval, and the challenging logistics of laboratory support, including diagnostics.
Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India
by Anand AM et al.Evaluation of NS1 antigen assay as an alternative to RT-PCR for the early diagnosis of dengue
The Use of a Dengue Rapid Diagnostic Test During Suspected Dengue Outbreaks in Resource Limited Regions
by Hunsperger EA et al.Evaluation of rapid diagnostic test for dengue virus
Vector control, surveillance, drugs, diagnostics and vaccines all hold exciting potential but none can solve the problem alone. We need an integrated approach.